PSMB5 and lung cancer: In this context, lung cancer cells with an upregulated PSMB5 H23 (425.1 nTPM (normalized transcript per million)) and H358 (349.9 nTPM) used in our current study are in accordance with the above mechanism, which could be an essential mediator of the effect of bortezomib itself but not in combination with PCC.